Adagio Medical Holdings (ADGM) Asset Writedowns and Impairment (2023 - 2024)
Adagio Medical Holdings (ADGM) reported Asset Writedowns and Impairment of -$15000.0 for Q3 2024, up 63.41% on a QoQ basis from -$41000.0 in Q2 2024.
Adagio Medical Holdings (ADGM) has 2 years of Asset Writedowns and Impairment data on file, last reported at -$15000.0 in Q3 2024.
- Quarterly Asset Writedowns and Impairment changed N/A year-over-year to -$15000.0 in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $30000.0 (changed N/A YoY) and the FY2024 annual result came in at $18.9 million, up 75412.0% from the prior year.
- Asset Writedowns and Impairment improved to -$15000.0 in Q3 2024 per ADGM's latest filing, from -$41000.0 in the prior quarter.
- Across five years, Asset Writedowns and Impairment topped out at $82000.0 in Q1 2024 and bottomed at -$41000.0 in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Adagio Medical Holdings | 16.86 Mn | 3.95 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -15,000.00 |
| Sep 30, 2024 | -15,000.00 |
| Jun 30, 2024 | -41,000.00 |
| Jun 30, 2024 | -41,000.00 |
| Mar 31, 2024 | 82,000.00 |
| Mar 31, 2024 | 82,000.00 |
| Dec 31, 2023 | 4,000.00 |
| Dec 31, 2023 | 4,000.00 |